![Laura Fletcher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Laura Fletcher
Directeur/Membre du Conseil chez
Stratosvir Ltd.
Profil
Prior to joining DSV, Laura was Associate Director of Cancer Research UK’s Commercial Partnerships team, heading the Strategic Alliances function which drives the charity’s strategic drug discovery and platform relationships with a range of commercial partners.
Her other experience at CRUK and Cancer Research Technology over 14 years included transacting a wide range of significant license, collaboration and spin out deals.
She holds a 1st class degree in Biochemistry and a PhD in cell signalling from the University of Bristol and has additionally worked in academic and commercial research roles in the US and the UK.
Postes actifs de Laura Fletcher
| Sociétés | Poste | Début |
|---|---|---|
Stratosvir Ltd.
 Stratosvir Ltd. Miscellaneous Commercial ServicesCommercial Services Develops viral immunotherapies to target cancer | Directeur/Membre du Conseil | 01/04/2021 |
Deep Science Ventures Ltd.
 Deep Science Ventures Ltd. Investment ManagersFinance Deep Science Ventures invests in private companies located in the United States and Europe. The firm focuses on sectors such as agriculture, computation, climate, and pharmaceuticals and education. It participates in pre-seed, seed, and early stage capital financing requirements. | Private Equity Investor | 01/01/2021 |
Neobe Therapeutics Ltd.
 Neobe Therapeutics Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology field | Directeur/Membre du Conseil | 14/04/2021 |
Anciens postes connus de Laura Fletcher
| Sociétés | Poste | Fin |
|---|---|---|
Cellinta Ltd.
 Cellinta Ltd. Investment ManagersFinance Functions as an alternative investment manager for healthcare industry | Directeur/Membre du Conseil | 31/12/2020 |
ProXara Biotechnology Ltd.
 ProXara Biotechnology Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of cancer | Fondateur | - |
Formation de Laura Fletcher
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
74
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ProXara Biotechnology Ltd.
ProXara Biotechnology Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of cancer | Health Technology |
Deep Science Ventures Ltd.
Deep Science Ventures Ltd. Investment ManagersFinance Deep Science Ventures invests in private companies located in the United States and Europe. The firm focuses on sectors such as agriculture, computation, climate, and pharmaceuticals and education. It participates in pre-seed, seed, and early stage capital financing requirements. | Finance |
Cellinta Ltd.
Cellinta Ltd. Investment ManagersFinance Functions as an alternative investment manager for healthcare industry | Finance |
Stratosvir Ltd.
Stratosvir Ltd. Miscellaneous Commercial ServicesCommercial Services Develops viral immunotherapies to target cancer | Commercial Services |
Neobe Therapeutics Ltd.
Neobe Therapeutics Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology field | Health Technology |
